Related Experiment Video
Updated: Apr 18, 2026
08:07
Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma
Published on: April 12, 2019
7.8K
Nanoparticle-based mechanistic and multifunctional strategies for targeted osteosarcoma therapy
Jie Cai1, Hulin Yang1, Zongxian He1
1Department of Orthopedics, The First People's Hospital of Xiaoshan District, Xiaoshan Affiliated Hospital of Wenzhou Medical University, Hangzhou, 311200, China.
Discover Nano
|April 16, 2026
Summary
Nanoparticles offer targeted delivery for osteosarcoma treatment, improving efficacy and reducing toxicity. Future research focuses on biodegradable, personalized nanoparticles and AI integration for better outcomes in pediatric bone cancer.
Area of Science:
- Biomedical Engineering
- Oncology
- Nanotechnology
Background:
- Osteosarcoma is a prevalent pediatric bone cancer with poor outcomes despite current treatments.
- Nanoparticles show promise for targeted drug delivery in osteosarcoma therapy.
- Stimulus-responsive nanoparticles offer enhanced precision by targeting tumor microenvironment cues.
Purpose of the Study:
- To review nanoparticle classifications and stimulus-responsive mechanisms for osteosarcoma therapy.
- To discuss current limitations and challenges in nanoparticle-based osteosarcoma treatment.
- To highlight future directions for optimizing nanoparticle design and clinical translation.
Main Methods:
- Literature review of nanoparticle classifications.
- Analysis of stimulus-responsive mechanisms in osteosarcoma.
- Discussion of challenges and future research directions.
Main Results:
- Nanoparticles provide selective drug delivery, controlled release, and multifunctional treatment options.
- Stimulus-responsive nanoparticles enhance therapeutic precision.
- Key challenges include biological toxicity, bioaccumulation, stability, and clearance.
Conclusions:
- Nanoparticles are a promising platform for advanced osteosarcoma therapy.
- Addressing challenges and developing biodegradable, personalized, and multifunctional nanoparticles is crucial.
- Integrating artificial intelligence can accelerate the clinical translation of these therapies.
Related Concept Videos
02:57Targeted Cancer Therapies
9.2K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.2K
01:24Site-Targeted Drug Delivery Systems: Polymeric Carriers
132
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
132
01:24Modified-Release Drug Delivery Systems: Site-Targeted
144
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
144
02:49Cancer Therapies
10.9K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.9K